Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1990 Dec;45(12):941–946. doi: 10.1136/thx.45.12.941

Lung function 8-18 years after intermittent positive pressure ventilation for hyaline membrane disease.

M J de Kleine 1, C M Roos 1, W J Voorn 1, H M Jansen 1, J G Koppe 1
PMCID: PMC462843  PMID: 2281428

Abstract

Lung function and respiratory symptoms were studied in 40 children aged 8-18 years who had been ventilated for hyaline membrane disease after birth; 11 had had bronchopulmonary dysplasia. Also studied were 38 age matched children who had had hyaline membrane disease but had not required ventilation, 25 unmatched children who were born prematurely but did not develop hyaline membrane disease, and 39 randomly selected pupils of similar age. There was no difference in thoracic gas volume, total lung capacity, inspiratory vital capacity, residual volume, or transfer factor for carbon monoxide between the groups. Respiratory symptoms during the three years before the study and the frequency of clinically diagnosed asthma in patients and their family were similar in all the children with hyaline membrane disease irrespective of whether they had been ventilated or had had bronchopulmonary dysplasia. The children with bronchopulmonary dysplasia, however, had a lower forced expiratory volume in one second (FEV1) before bronchodilator (73% predicted) than the other groups (88-95% predicted). Children who had required ventilation had lower values for specific airways conductance (sGaw) and a greater increase in FEV1 (delta FEV1) after salbutamol (13%) than non-ventilated children (6%); delta FEV1 was associated with the peak pressure of intermittent positive pressure ventilation, a family history of asthma and a history of wheezing, recurrent respiratory illnesses, and a doctor's diagnosis of asthma during the three years before the study. These findings indicate that after eight years of age patients with bronchopulmonary dysplasia have more reversible airways obstruction, compatible with increased bronchial smooth muscle tone.

Full text

PDF
941

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BLAKEMORE W. S., FORSTER R. E., MORTON J. W., OGILVIE C. M. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest. 1957 Jan;36(1 Pt 1):1–17. doi: 10.1172/JCI103402. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bader D., Ramos A. D., Lew C. D., Platzker A. C., Stabile M. W., Keens T. G. Childhood sequelae of infant lung disease: exercise and pulmonary function abnormalities after bronchopulmonary dysplasia. J Pediatr. 1987 May;110(5):693–699. doi: 10.1016/s0022-3476(87)80004-5. [DOI] [PubMed] [Google Scholar]
  3. Bancalari E., Gerhardt T. Bronchopulmonary dysplasia. Pediatr Clin North Am. 1986 Feb;33(1):1–23. doi: 10.1016/s0031-3955(16)34967-7. [DOI] [PubMed] [Google Scholar]
  4. Bertrand J. M., Riley S. P., Popkin J., Coates A. L. The long-term pulmonary sequelae of prematurity: the role of familial airway hyperreactivity and the respiratory distress syndrome. N Engl J Med. 1985 Mar 21;312(12):742–745. doi: 10.1056/NEJM198503213121202. [DOI] [PubMed] [Google Scholar]
  5. Casan P., Roca J., Sanchis J. Spirometric response to a bronchodilator. Reference values for healthy children and adolescents. Bull Eur Physiopathol Respir. 1983 Nov-Dec;19(6):567–569. [PubMed] [Google Scholar]
  6. Coates A. L., Desmond K., Willis D., Nogrady M. B. Oxygen therapy and long-term pulmonary outcome of respiratory distress syndrome in newborns. Am J Dis Child. 1982 Oct;136(10):892–895. doi: 10.1001/archpedi.1982.03970460022005. [DOI] [PubMed] [Google Scholar]
  7. DeGroodt E. G., van Pelt W., Borsboom G. J., Quanjer P. H., van Zomeren B. C. Growth of lung and thorax dimensions during the pubertal growth spurt. Eur Respir J. 1988 Feb;1(2):102–108. [PubMed] [Google Scholar]
  8. Degroodt E. G., Quanjer P. H., Wise M. E., van Zomeren B. C. Changing relationships between stature and lung volumes during puberty. Respir Physiol. 1986 Aug;65(2):139–153. doi: 10.1016/0034-5687(86)90046-0. [DOI] [PubMed] [Google Scholar]
  9. Driscoll D. J., Kleinberg F., Heise C. T., Staats B. A. Cardiorespiratory function in asymptomatic survivors of neonatal respiratory distress syndrome. Mayo Clin Proc. 1987 Aug;62(8):695–700. doi: 10.1016/s0025-6196(12)65222-7. [DOI] [PubMed] [Google Scholar]
  10. Ekwo E. E., Weinberger M. M., Dusdieker L. B., Huntley W. H., Rodgers P., Maxwell G. A. Airways responses to inhaled isoproterenol in normal children. Am Rev Respir Dis. 1983 Jan;127(1):108–109. doi: 10.1164/arrd.1983.127.1.108. [DOI] [PubMed] [Google Scholar]
  11. Farrell P. M., Avery M. E. Hyaline membrane disease. Am Rev Respir Dis. 1975 May;111(5):657–688. doi: 10.1164/arrd.1975.111.5.657. [DOI] [PubMed] [Google Scholar]
  12. Gerhardt T., Hehre D., Feller R., Reifenberg L., Bancalari E. Serial determination of pulmonary function in infants with chronic lung disease. J Pediatr. 1987 Mar;110(3):448–456. doi: 10.1016/s0022-3476(87)80516-4. [DOI] [PubMed] [Google Scholar]
  13. Goetzman B. W. Understanding bronchopulmonary dysplasia. Am J Dis Child. 1986 Apr;140(4):332–334. doi: 10.1001/archpedi.1986.02140180066026. [DOI] [PubMed] [Google Scholar]
  14. Goldman S. L., Gerhardt T., Sonni R., Feller R., Hehre D., Tapia J. L., Bancalari E. Early prediction of chronic lung disease by pulmonary function testing. J Pediatr. 1983 Apr;102(4):613–617. doi: 10.1016/s0022-3476(83)80202-9. [DOI] [PubMed] [Google Scholar]
  15. Heldt G. P., McIlroy M. B., Hansen T. N., Tooley W. H. Exercise performance of the survivors of hyaline membrane disease. J Pediatr. 1980 Jun;96(6):995–999. doi: 10.1016/s0022-3476(80)80624-x. [DOI] [PubMed] [Google Scholar]
  16. Keuskamp D. H. Ventilation of premature and newborn infants. Int Anesthesiol Clin. 1974 Winter;12(4):281–307. doi: 10.1097/00004311-197412040-00016. [DOI] [PubMed] [Google Scholar]
  17. Knudson R. J., Kaltenborn W. T., Knudson D. E., Burrows B. The single-breath carbon monoxide diffusing capacity. Reference equations derived from a healthy nonsmoking population and effects of hematocrit. Am Rev Respir Dis. 1987 Apr;135(4):805–811. doi: 10.1164/arrd.1987.135.4.805. [DOI] [PubMed] [Google Scholar]
  18. Lamarre A., Linsao L., Reilly B. J., Swyer P. R., Levison H. Residual pulmonary abnormalities in survivors of idiopathic respiratory distress syndrome. Am Rev Respir Dis. 1973 Jul;108(1):56–61. doi: 10.1164/arrd.1973.108.1.56. [DOI] [PubMed] [Google Scholar]
  19. Lebowitz M. D., Holberg C. J., Knudson R. J., Burrows B. Longitudinal study of pulmonary function development in childhood, adolescence, and early adulthood. Development of pulmonary function. Am Rev Respir Dis. 1987 Jul;136(1):69–75. doi: 10.1164/ajrccm/136.1.69. [DOI] [PubMed] [Google Scholar]
  20. MacLusky I. B., Stringer D., Zarfen J., Smallhorn J., Levison H. Cardiorespiratory status in long-term survivors of prematurity, with and without hyaline membrane disease. Pediatr Pulmonol. 1986 Mar-Apr;2(2):94–102. doi: 10.1002/ppul.1950020207. [DOI] [PubMed] [Google Scholar]
  21. Mansell A. L., Driscoll J. M., James L. S. Pulmonary follow-up of moderately low birth weight infants with and without respiratory distress syndrome. J Pediatr. 1987 Jan;110(1):111–115. doi: 10.1016/s0022-3476(87)80301-3. [DOI] [PubMed] [Google Scholar]
  22. Northway W. H., Jr, Rosan R. C., Porter D. Y. Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967 Feb 16;276(7):357–368. doi: 10.1056/NEJM196702162760701. [DOI] [PubMed] [Google Scholar]
  23. O'Brodovich H. M., Mellins R. B. Bronchopulmonary dysplasia. Unresolved neonatal acute lung injury. Am Rev Respir Dis. 1985 Sep;132(3):694–709. doi: 10.1164/arrd.1985.132.3.694. [DOI] [PubMed] [Google Scholar]
  24. Riedel F. Long term effects of artificial ventilation in neonates. Acta Paediatr Scand. 1987 Jan;76(1):24–29. doi: 10.1111/j.1651-2227.1987.tb10409.x. [DOI] [PubMed] [Google Scholar]
  25. Rijcken B., Schouten J. P., Weiss S. T., Speizer F. E., van der Lende R. The relationship of nonspecific bronchial responsiveness to respiratory symptoms in a random population sample. Am Rev Respir Dis. 1987 Jul;136(1):62–68. doi: 10.1164/ajrccm/136.1.62. [DOI] [PubMed] [Google Scholar]
  26. Salome C. M., Peat J. K., Britton W. J., Woolcock A. J. Bronchial hyperresponsiveness in two populations of Australian schoolchildren. I. Relation to respiratory symptoms and diagnosed asthma. Clin Allergy. 1987 Jul;17(4):271–281. doi: 10.1111/j.1365-2222.1987.tb02015.x. [DOI] [PubMed] [Google Scholar]
  27. Schmand B., Neuvel J., Smolders-de Haas H., Hoeks J., Treffers P. E., Koppe J. G. Psychological development of children who were treated antenatally with corticosteroids to prevent respiratory distress syndrome. Pediatrics. 1990 Jul;86(1):58–64. [PubMed] [Google Scholar]
  28. Schutte M. F., Treffers P. E., Koppe J. G., Breur W. The influence of betamethasone and orciprenaline on the incidence of respiratory distress syndrome in the newborn after preterm labour. Br J Obstet Gynaecol. 1980 Feb;87(2):127–131. doi: 10.1111/j.1471-0528.1980.tb04505.x. [DOI] [PubMed] [Google Scholar]
  29. Stahlman M., Hedvall G., Lindstrom D., Snell J. Role of hyaline membrane disease in production of later childhood lung abnormalities. Pediatrics. 1982 May;69(5):572–576. [PubMed] [Google Scholar]
  30. Stenius-Aarniala B., Piirilä P., Teramo K. Asthma and pregnancy: a prospective study of 198 pregnancies. Thorax. 1988 Jan;43(1):12–18. doi: 10.1136/thx.43.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Tooley W. H. Epidemiology of bronchopulmonary dysplasia. J Pediatr. 1979 Nov;95(5 Pt 2):851–858. doi: 10.1016/s0022-3476(79)80451-5. [DOI] [PubMed] [Google Scholar]
  32. Zapletal A., Paul T., Samanek M. Pulmonary elasticity in children and adolescents. J Appl Physiol. 1976 Jun;40(6):953–961. doi: 10.1152/jappl.1976.40.6.953. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES